Mesenchymal differentiation and organ distribution of established human stromal cell lines in NOD/SCID mice

被引:32
作者
Thalmeier, K
Meissner, P
Moosmann, S
Sagebiel, S
Wiest, I
Huss, R
机构
[1] Univ Munich, Inst Pathol, D-80337 Munich, Germany
[2] Micromet AG, Munich, Germany
[3] Tech Univ Munich, Klinikum Rechts Isar, Dept Otorhinolaryngol Head & Neck Surg, D-8000 Munich, Germany
关键词
stromal cells; mesenchymal stem cell; osteoblast; osteogenesis;
D O I
10.1159/000046559
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Two human stromal cell lines were established previously from bone marrow-derived primary long-term cultures by immortalization using the SV40 large T antigen and cellular cloning. After irradiation, the fibroblast-like cell lines L87/4 and L88/5 support hematopoietic differentiation of allogeneic cord blood cells in vitro. The stromal cells do not express CD34 and CD50, but some adhesion molecules and integrins, such as CD44, CD54 and CD58. Their expression profiles on RNA and protein levels are suggestive of their osteogenic potency. The quality and quantity of osteocalcin and osteopontin protein expression depended on the culture conditions. Expression of the osteogenic markers increased over time in culture, especially in cells growing in clusters. The stromal cells also expressed collagens I and V, but did not show any expression of collagens II and III. The potentially osteoblastic stromal cells were transplanted into NOD/SCID recipient mice by intravenous injection and were found in various mesenchymal organs up to 10 weeks after transplantation. Osteocalcin-positive human stromal cells could be detected in the bone marrow, thymus, liver, brain and gut of the recipient animals. In summary, there is evidence that human bone-marrow-derived stromal cells have to be considered mesenchymal progenitors, persistently expressing osteogenic markers in vitro and in vivo. Copyright (C) 2001 S, Karger AG, Basel.
引用
收藏
页码:159 / 165
页数:7
相关论文
共 28 条
[1]   A newly discovered class of human hematopoietic cells with SCID-repopulating activity [J].
Bhatia, M ;
Bonnet, D ;
Murdoch, B ;
Gan, OI ;
Dick, JE .
NATURE MEDICINE, 1998, 4 (09) :1038-1045
[2]   Nuclear matrix proteins and osteoblast gene expression [J].
Bidwell, JP ;
Alvarez, M ;
Feister, H ;
Onyia, J ;
Hock, J .
JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (02) :155-167
[3]   The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ [J].
Chesney, J ;
Bacher, M ;
Bender, A ;
Bucala, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) :6307-6312
[4]   Mesenchymal stem cells: Biology and potential clinical uses [J].
Deans, RJ ;
Moseley, AB .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (08) :875-884
[5]   Muscle regeneration by bone marrow derived myogenic progenitors [J].
Ferrari, G ;
Cusella-De Angelis, G ;
Coletta, M ;
Paolucci, E ;
Stornaiuolo, A ;
Cossu, G ;
Mavilio, F .
SCIENCE, 1998, 279 (5356) :1528-1530
[6]   Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo [J].
Goodell, MA ;
Brose, K ;
Paradis, G ;
Conner, AS ;
Mulligan, RC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1797-1806
[7]   THE STRO-1(+) FRACTION OF ADULT HUMAN BONE-MARROW CONTAINS THE OSTEOGENIC PRECURSORS [J].
GRONTHOS, S ;
GRAVES, SE ;
OHTA, S ;
SIMMONS, PJ .
BLOOD, 1994, 84 (12) :4164-4173
[8]   Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta [J].
Horwitz, EM ;
Prockop, DJ ;
Fitzpatrick, LA ;
Koo, WWK ;
Gordon, PL ;
Neel, M ;
Sussman, M ;
Orchard, P ;
Marx, JC ;
Pyeritz, RE ;
Brenner, MK .
NATURE MEDICINE, 1999, 5 (03) :309-313
[9]   FORMATION OF HEMATOPOIETIC MICROENVIRONMENT AND HEMATOPOIETIC STEM-CELLS FROM SINGLE HUMAN BONE-MARROW STEM-CELLS [J].
HUANG, S ;
TERSTAPPEN, LWMM .
NATURE, 1992, 360 (6406) :745-749
[10]  
HUANG S, 1994, NATURE, V368, P364